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Although results from multicenter trials have been mixed (1, 2), most single- 
center studies have shown that HLA-DR matching leads to significant improve- 
ment in human  renal allograft survival (3, 4).  The true effect of matching may 
have been clouded by pharmacologic  immunosuppression  and,  more recently, 
by the addition of aggressive pretransplant  blood transfusions (2, 4).  Studies of 
the role of class II antigen  matching  in rodents in the absence of other immu- 
nosuppression  have  yielded conflicting  results,  with  one group reporting  pro- 
longed survival with matching (5) and another group finding no effect (6). Even 
if the effect of matching was consistently found in rodents, the recent reports of 
Hart  and  Fabre  (7,  8),  showing  differential  anatomical  distribution  between 
rodents and man of class II antigens on vascular endothelium, a potential site of 
recipient/donor immune interaction, suggest that conclusions may not be directly 
transferable to man. The use of large-animal  models in which the effect of class 
II  matching  have  been  studied  have  been  difficult.  In  general,  they have  de- 
pended on rare  recombinants  among siblings or have used mixed  lymphocyte 
nonreactivity and  serologic class II antigen  typing to identify class II identical 
animals (9).  These methods have been limited by the inability to repeat results 
with the same matched combinations, coupled with the uncertainty of genotypic 
class II identity because of limited typing reagents. 
Studies  of transplantation  biology in  this  laboratory  have  made  use of our 
partially inbred miniature swine (10). Because they are defified only at the major 
histocompatibility  complex  (MHC), 1 they  provide  a  closer  model  for  human 
transplantation  studies than do inbred rodent species. The recent identification 
of a recombinant haplotype (11) has now enabled us to test the effect of isolated 
class  I  and  II  antigen  matching  in  this  large-animal  model.  This  recombinant 
haplotype,  SLA  g,  has  been  demonstrated  by serology, protein  chemistry,  and 
restriction  digest  mapping  of DNA  (D.  Singer  and  D.  H.  Sachs,  unpublished 
results) to contain the class I antigens of the c haplotype and the class II antigens 
of the  d  haplotype.  We have  also recently demonstrated  in  our herd  that  the 
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expression of class II MHC antigens on vascular endothelium is identical to that 
of man  (12).  Renal  allograft  survival  in  nonrecombinant  miniature  swine  has 
previously been shown to be correlated with MHC matching (13). In addition, a 
non-MHC-linked  immune  response  gene has  been  shown  to further  regulate 
survival  of completely  matched  grafts,  such  that  recipients  lacking  a  rejector 
gene  were  tolerant  of the  MHC-matched  graft  despite  multiple  mismatched 
minor histocompatibility antigens (14). In preliminary studies of transplants using 
the  recombinant  animals,  a  beneficial  role  of class  II  matching  alone  in  two 
animals  was  found  (15).  We  have  therefore extended  these  studies  and  now 
report that overall survival of class II only-matched kidneys is clearly prolonged 
over completely mismatched or class  I  only-matched kidneys.  In addition,  we 
show  that  this  prolongation  is  dependent  on  MHC  gene  dose  differences,  is 
subject  to  the  effects of both  MHC-iinked  and  MHC-unlinked  genes,  and  is 
associated with specific systemic tolerance. 
Materials and Methods 
Animals.  Three herds of miniature swine, selectively inbred for the porcine MHC, 
swine leukocyte antigen (SLA), with haplotypes designated a, c, and d, have previously 
been described (10), as has a recently derived recombinant haplotype designated g (11). 
All animals were bred and maintained at the NIH Animal Center, Poolesville, MD. 
Kidney Transplants.  Animals used for transplantation were 3-6 mo old and weighed 
20-40  kg.  The technique of renal  allografting has  been described (13).  Briefly, two 
animals were subjected to bilateral nephrectomy and reciprocal exchange of one kidney. 
In certain instances, one animal served as a donor for two recipients. Transplants were 
placed orthotopically using a Carrel patch arterial anastomosis and end-to-end venous and 
ureteral anastomoses. Serial serum creatinine and blood urea nitrogen (BUN) levels were 
obtained to assess renal function after transplant. These values paralleled each other with 
rejection, so only BUN values are shown in the results. Occasional animals whose BUN 
increased between days 2 and  3 were surgically explored for a  possible ureteral leak, 
which was  repaired if detected. Rejection was defined as death of the animal with an 
associated decrease in renal function and confirmatory gross and pathologic findings. No 
exogenous immunosuppression was administered, nor were animals given blood transfu- 
sions. 
Skin Grafts.  Split-thickness skin grafts were placed on renal allograft recipients that 
had survived beyond 3 mo, or on normal matched controls. The skin was either fresh (if 
the renal donor was alive) or frozen (taken at the time of renal transplant). The graft bed 
was prepared with a single pass of a disposable electric Davol Dermatome (Davol, Inc., 
Cranston,  RI).  An  occlusive compression  dressing  was  removed on  day  3  after skin 
grafting.  The day of rejection was  defined as  the point at  which the skin  was  totally 
necrotic. 
Posttransplantation Antibody Response.  Pretransplant and weekly posttransplant serial 
serum  samples were tested for alloantibody responses using a  two-stage, complement- 
dependent cytotoxicity assay  (10) on Ficoil/Hypaque-purified peripheral blood lympho- 
cytes.  Either  trypan  blue  exclusion  or  51Cr release  was  used  to  assess  percent  lysis. 
Maximum release for the 5~Cr assay was determined by the lysis caused by 1 N  HCI and 
the background was complement alone. Hyperimmune allosera (10) were included in all 
assays as positive controls. 
2-Mercaptoethanol Treatment of Serum.  To distinguish between IgM vs. IgG alioanti- 
bodies,  posttransplant  sera  were diluted  1:1  with  phosphate-buffered saline  (PBS).  2- 
Mercaptoethanol  (Bio-Rad  Laboratories,  Richmond,  CA)  was  then  added  to  a  final 
concentration of 0.1 M. The samples were incubated for 30 min at 37°C and then dialyzed 
against  PBS.  Control samples were  treated identically, but no  2-mercaptoethanol was PESCOVITZ ET  AL.  1497 
added.  The  treated  samples  were  then  tested  for  cytotoxic activity in  a  two-stage, 
complement-dependent assay. 
Statistical Analysis.  Survival times are reported as mean +  SD. Statistical  significance 
was calculated on a Wang 2200 computer using either a Student's two-tailed t test with 
degrees of freedom (df) calculated assuming unequal standard deviation, or a  2  x  2 
contigency table for Chi square analysis. 
Results 
Experimental Protocol.  The discovery and propagation of the recombinant g 
haplotype (11) allowed selective transplantation across either class I  or class II 
differences (Fig. 1). Because these animals were not fully inbred, multiple minor 
antigen differences were also present (13). Thus, transplants between animals of 
the d and g  haplotypes resulted in class II-matched, class I-mismatched grafts. 
Alternatively, transplants between animals of the g and c haplotype resulted in 
class I-matched, class II-mismatched grafts. Finally, transplants between animals 
of the c and d haplotype resulted in both class I- and class II-mismatched grafts. 
Also  shown  in  Fig.  1  is  the  a  haplotype  used  in  heterozygous recipients.  By 
selecting homozygous or heterozygous recipient pairs, the effect of MHC gene 
dose could also be studied.  No immunosuppressive therapy was used, to avoid 
confounding the effect of MHC matching. 
Graft Survival as Controlled  by MHC Antigen Mismatch.  Fig. 2 shows the overall 
results obtained with the four types of MHC matching: none, complete, class I, 
or  class  II.  Deaths  from  all  causes  beyond  the  first  week  are  included.  In 
confirmation of early work in this model, completely mismatched grafts were 
rapidly and uniformly rejected with a  mean survival time of 12 -  1.9 d. MHC- 
matched grafts showed prolonged survival over complete mismatches.  Also as 
demonstrated  previously  (13),  a  percentage  of these  matched  grafts  enjoyed 
permanent acceptance with normal renal function, despite multiple mismatches 
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FIGURE 2.  Life  table survival of  renal allografts in miniature swine. Survival curves  are shown 
for each type of antigen mismatch. Deaths from all  causes  after  a technically successful 
transplant are included. The number of animals in each group are indicated in the legend, as 
well as the number of animals alive at various points for class II-matched and class I plus class 
II-matched grafts. 
at non-MHC  loci.  In  fact,  with  few exceptions, all  deaths  beyond  100 d  were 
from causes other than rejection. As mentioned in the introduction, this survival 
was previously found to be regulated by a  non-MHC-linked  immune response 
gene(s) (I 4). 
After reconfirming the effect of matching for the whole MHC, the effect of 
partial MHC matching was studied. Class I-matched, class II-mismatched grafts, 
(all ag/ac combinations) although prolonged over completely mismatched grafts, 
were all rejected with a survival time of 21.8 +_  10.4 d  (P =  0.086,  11  df). The 
most striking results were seen in the group that received class II-matched, class 
I-mismatched  grafts.  While  the  percentage  of early  deaths  in  this  group  was 
nearly  the  same  for  that  of class  I-matched  grafts,  by day  30  posttransplant, 
these  two  survival  curves  separated,  and  the  class  II-matched  graft  survival 
paralleled and eventually equalled that  of the fully matched grafts.  Therefore, 
class II-matched grafts showed a bimodal distribution in survival with the long- 
term survival equaling that of complete MHC-matched grafts. 
Prolonged Survival of Class II-matched Grafts Analyzed by Specific Donor~Recipient 
Pairs.  The bimodal survival seen in Fig. 2 suggested that certain animals had a 
greater tendency to reject class II-matched,  class I-mismatched renal allografts 
than did others. To examine this possibility, class II-matched grafts were divided 
into groups by recipient/donor combinations (Fig. 3). This analysis demonstrated 
that prolonged survival of the allograft was associated nonrandomly with certain 
combinations.  Additionally, it suggested that at least three genetic factors regu- 
lated  length  of allograft  survival,  namely  donor  MHC gene  dose,  a  recipient 
MHC-linked effect, and a recipient non-MHC-linked effect (possibly an immune 
response gene). The effect of MHC gene dose can be seen in several groups: All 
dd animals rejected their class II-matched renal grafts, but recipients of haplo- 
identical (dg) grafts showed longer survival (26.8 -+ 7.4 d) than those recipients PESCOVITZ  ET  AL.  1499 
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Animals  still alive. (0) Animals that died from rejection. A superscript 1 indicates animals that 
died from nonrenal causes. Each circle indicates one animal. 
of homozygous (gg)  grafts (15.4 +  3.3 d) (groups 6 and 7; P  =  0.0068,  7 df). 
Also, all gg recipients of dd grafts died of rejection, whereas no recipients of dg 
grafts died of rejection (groups 3 and 4; P <  0.005, 1 df, Chi square). The MHC- 
linked effect was seen by comparing results in the dd animals with results in gg 
animals.  All dd recipients rejected their class II-matched, dg grafts (group 6). 
Similar dg kidneys, however, were not rejected by gg recipients (group 3; P  < 
0.005,  1 df, Chi square).  Since the only clear difference between the g  and d 
haplotypes involves the class  I  MHC  antigens,  this phenomenon is apparently 
class I  dependent. Possible mechanisms for this effect are addressed further in 
the Discussion. The a  haplotype appeared to function in a permissive role, since 
a percentage of ad animals tolerated ag (group 5) or gg kidneys (data not shown), 
whereas  none of the  homozygous dd  animals  permanently accepted  class  I- 
mismatched  grafts.  Finally,  a  non-MHC-linked  immune  response  gene  was 
suggested by the bimodal distribution in survival observed in groups 1, 2, 4, and 1500  PROLONGED  SURVIVAL  OF  CLASS  II  MATCHED  RENAL  ALLOGRAFTS 
5. Approximately half of the animals died of rejection at times equal to the class 
I-matched, class  II-mismatched grafts (Fig.  2).  The remainder of the animals, 
with  the  exception  of  group  4,  showed  permanent  allograft  survival.  This 
immune response gene effect is similar to that previously reported for MHC- 
matched grafts (14).  MHC gene dose had an opposite effect, since two animals 
in group 4, although surviving for prolonged periods, did eventually succumb 
to chronic rejection. 
Evidence for an Anti-allograft  Immune Response in Long-term Survivors.  Howard 
and  Butcher  (16)  have  suggested  that  long-term  survival  of class  I,  MHC- 
mismatched skin grafts in certain rat strains results from the lack of an immune 
response  to  these MHC  antigens, as determined by antibody production and 
cellular reactivity. It seems unlikely, however, that this was the basis of prolonged 
survival in our pigs, since a definite anti-allograft response, indicated by decreas- 
ing renal function and anti-donor MHC antibodies, was found beginning ~ 10 d 
posttransplant. In those animals that succumbed, the BUN increased until death 
(Fig. 4A), while in the pigs that survived, renal function improved and eventually 
returned to pretransplant levels. In certain instances, the damage induced during 
the limited rejection crisis was more severe and apparently repaired more slowly 
(compare Fig.  4,  B  and C).  After the recovery period,  with  the exception of 
group 4 (Fig.  3), there was never a secondary rise in BUN due to rejection. In 
this group, the two long-term survivors had a slight initial improvement in renal 
function before continuing with a slow chronic decrease in function until death 
from uremia.  Additional  evidence for an  anti-allograft immune response was 
found in  the few animals that died from nonrenal causes during the recovery 
phase. In these animals, cellular infiltrates consistent with rejection were found. 
All animals that rejected their ailografts, and 6 out of 15 nonrejecting animals 
that were tested, had detectable levels of antibody against the renal donor MHC 
haplotype. Table I  shows six animals, half of which were acceptors, that dem- 
onstrated antibodies specifically reactive against cells of the mismatched donor 
class  I  MHC haplotype, d, but not the self class  I  MHC haplotype, c.  Positive 
controls, animals immunized by skin grafts (10), lysed >80% of cells with titers 
of 256  or greater (data not shown). As seen in  Table  I, acceptor animal sera 
were lower titered and killed a  lower percentage of cells than rejector animal 
sera or positive control sera.  In  one animal  (916  ag), lysis  directed toward a 
minor antigen was found, in addition to that directed toward the MHC antigens. 
This  reactivity was  also  present  in  the  pretransplant  sera.  The  peak  of the 
antibody response in  the acceptors was at  2  wk,  with disappearance by 4  wk, 
except in one animal (916) (Fig. 4, B and C), while antibodies persisted for >6 
wk in animals that rejected skin grafts or in  nonnephrectomized animals that 
rejected a transplanted kidney (data not shown). With the exception mentioned 
above,  pretransplant  sera  had  no  cytotoxic  activity.  These  data,  therefore, 
demonstrated that  kidney aliografts  induce an  immune response in  the long- 
term survivors of class II-matched, class I-mismatched allografts, but that some 
other host mechanism(s) lead to curtailment of this immune response. 
Isotype  Class  of the  Antibody  Response.  Several  possible  explanations  were 
suggested for the short duration of the antibody response. The appearance of 
inhibitory material (e.g., antiidiotypic antibodies or anticomplementarity) was an A
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TABLE  I 
Postrenal Transplant Antibody Response: Evidence  for MHC Linkage of Target Antigens 
Recipient  Donor  No./ 
No./haplo-  haplotype 
type 
Target cells (animal No./haplotype) 
158 dd  882 dd  1100 dd  457 c¢  869 cc  909 cc  441 cc 
920 ag*  885 dd  1:512 (90)*  ND  >256 (100)  0  0  O  0 
933 ag  949 ad  1:128 (90)  ND  1:256 (100)  0  0  0  0 
981 ag  1,004 ad  >256 (100)  1:128 (100)  >256 (100)  0  0  0  0 
983 gg  979 dg  1:64 (49)  1:32 (88)  1:64 (75)  0  0  0  0 
936 ag  950 ad  1:32 (35)  1:32 (55)  1:64 (31)  0  0  0  0 
982 ag  1,002 ad  1:64 (38)  1:128 (77)  1:128 (54)  0  0  0  0 
916 ag  910 ad  1:128 (86)  1:64 (54)  1:256 (27)  O  1:128 (46)  I  1:128 (45)  0 
* All sera are 2 wk posttransplant,  Animals 920, 933, and 981 died from rejection at 2 wk. 
* Titer (percent release Cr  51) in a two-stage complement-dependent  cytotoxicity assay on peripheral blood lymphocytes. 
I Cytotoxicity against these cc targets by No, 916 was seen in pretransplant  sera. All other pretransplant sera were negative. 
90i 
i 
6O 
x 
0 
ACCEPTORS 
-2ME  +2ME 
916 ~  --e-  --e-- 
936ag  ~  -~¢z-- 
982 ag  --IO--  -O'- 
8  16  32  64  128  256 
REJECTORS 
.  -2ME  +2ME 
o 
~(~  ~,  ~  981 ag ~  --[3-- 
=  1  i  ,  =  1  1  t  ~ 
4  8  16  32  64  128  256 512 1024 2048 
SERUM DILUTION-' 
FIGURE  5.  IgM vs. IgG antibody response in posttransplant animals. 2  wk sera from animals 
that A,  subsequently survived their renal allografts (916,  936,  and  982)  or B,  from  animals 
that rejected their kidney (981), skin (992),  or hyperimmune  sera (717), were treated with 2- 
mercaptoethanol,  0.1  M,  for  1  h  at  37°C.  Titer  and  percent  cytotoxicity as determined  by 
complement-dependent  lysis on NaS=CrO4-1abeled dd peripheral blood lymphocytes are shown. 
Control samples (solid lines) received identical treatment, but were not exposed to 2-mercap- 
toethanol. 
unlikely explanation, since the mixing of late noncytotoxic serum samples with 
earlier cytotoxic samples only resulted in a decrease in cytotoxic activity, explain- 
able by dilution (data not shown). Since the cytotoxic activity was only seen early, 
it was reasoned that the antibodies might be of the IgM class.  Consistent with 
this hypothesis, the cytotoxic activity was sensitive to 2-mercaptoethanol (Fig. 5), PESCOVITZ  ET  AL.  1503 
which  is known  to disrupt  IgM  antibodies  (17).  When  2-wk  sera from animals 
that were rejecting similarly matched kidney or skin grafts were subjected to the 
same 2-mercaptoethanol treatment, at most a 50% reduction in activity was seen. 
This implies that at 2 wk, an IgG response was possible, but that in those animals 
that  survived  the  kidney  transplant,  a  detectable  switch  from  IgM  to  IgG 
production did not occur. 
Evidence for Systemic Tolerance in Long-term Survivors.  Animals that had sur- 
vived class  I-mismatched,  class  II-matched  renal  allografts  were  grafted  with 
skin from the same renal donor or third-party, class II-mismatched animals. Skin 
grafts from the renal donor to renal recipient showed prolonged survival (31.7 
__. 20.4 d) over similar class I-mismatched skin grafts placed on control animals 
(11.67  +  2.6 d, P  =  0.043,  5  df) and over third-party skin grafts on renal graft 
recipients (Fig. 6). Although prolonged, all skin grafts were eventually rejected. 
At the time of rejection  there was no decrease in renal function, as determined 
by  measurement  of serum  BUN  or  creatinine,  nor  did  anti-donor  cytotoxic 
serum antibodies appear. These results implied that tolerance to MHC antigens 
and perhaps  to kidney-specific  antigens  was present.  They also  suggested  that 
skin-specific antigens may have been responsible for eventual rejection. 
100  :.,J LI 
9O 
8O 
70  - 
60  - 
50  - 
40  - 
30  - 
20  - 
10  - 
> 
> 
g 
<c 
z 
tt3 
E 
& 
O..- 
I... 
Recipient  Source  Number  of 
Type  of Skin  Animals 
~  Kidney  Recipient  Kidney  Donor  6 
Class II  Matched 
e--4  Kidney  Recipient  Third  Party  4 
Class II  Mismatched 
e. *-o  Normal  Control  Class II  Matched  9 
l 
1 
II 
v 6O 
&l  ~.  I  I  I  I 
0  10  20  30  40  50 
DAYS  POST  SKIN  GRAFT 
FIGURE 6.  Skin graft  survival in  recipients tolerant of class  II-matched  renal a]logTafts. 
Animals  tolerant  of renal  allografts  for >90 d  underwent  split-thickness  skin grafts  from  the 
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Discussion 
The effect of DR matching on renal allografts in inbred miniature swine has 
been studied. These transplants are analogous to human, living, related donor 
transplants with identifiable MHC differences and limited unidentifiable minor 
histocompatibility differences. The existence of a recently derived, well-charac- 
terized recombinant haplotype (10) offers an advantage to this system over others 
such  as  monkeys or  dogs,  since  use  of this  recombinant  haplotype  permits 
complete genotypic matching for the class  II antigens. In rhesus as in humans, 
the ability to identify DR matches is limited by the availability of typing reagents 
(18).  In fact, in  monkeys, serologic DR matching is associated with a  20-30% 
cellular  D  region  mismatch,  implying additional  undetected, class  II  antigen 
mismatching  or  a  class  I-specific  mixed  leukocyte  reaction  (MLR).  In  our 
miniature swine, genetic and serologic DR matching only occasionally resulted 
in a limited MLR response (19), which could be blocked by class I-specific sera 
(M.  Pescovitz, unpublished observations).  Using these animals, without exoge- 
nous immunosuppression and despite known class I MHC antigen mismatches, a 
clear benefit for class  II antigen matching was seen. In fact, long-term survival 
after class II-only matched grafts equaled that of MHC-matched grafts. 
The survival pattern of class II-matched grafts suggested a bimodal distribu- 
tion, with some animals rejecting their allografts at times only slightly prolonged 
over mismatched grafts.  A  similar bimodal  distribution  has been reported in 
Rhesus  monkeys (20)  and  has  been  suggested  in  humans when  time to  first 
rejection episodes  was  examined (21).  By performing transplants  in  multiple 
different donor/recipient  combinations,  a  pattern  of survival  resulted  which 
suggested three important factors for survival, each of which will be discussed 
separately. 
First,  the data suggest an effect of mismatched MHC gene dose.  Improved 
survival of haploidentical grafts has been reported in other experimental renal 
allograft systems (22,  23).  The  actual  mechanism is  uncertain  both  in  these 
reports and  in  the pig.  Whether it  results  from an effect on  the afferent or 
efferent arm  of the  immune  response  is  not  clear.  MLR  and  ceil-mediated 
lympholysis reactions are generally less vigorous between haploidentical porcine 
cells than between homozygous animals, although  there is wide variation (M. 
Pescovitz,  unpublished observation).  However, homozygous and heterozygous 
target cells are lysed equally well  by a  single cytotoxic T  lymphocyte (CTL) 
effector population,  providing no obvious correlation between in vitro and in 
vivo MHC gene dose effects. 
Second, there appears to be an MHC-linked effect on survival. Since the only 
MHC  differences between  the  dd recipients  that  reject dg grafts  and  the gg 
recipients that accept dg grafts are the class  I  MHC  antigens, this apparently 
maps this effect to the class I antigens. This could imply a class I immune response 
gene, although the fact that heterozygous ad animals sometimes accept grafts 
would mitigate against this possibility, since it would make the gene recessive. 
Evidence for MHC-linked higher rejection rates exists in several other species, 
including rodent and man. The MHC-linked immune response gene for MHC 
antigens reported for rats was also seen for a class  I antigen mismatch (16).  In 
these experiments, along with the failure to reject skin,  the rats also failed to PESCOVITZ  ET  AL.  1505 
make antibodies or in vivo CTL to the mismatched antigens and the effect was 
shown to be dominant. The swine reported here differ in that skin grafts were 
rejected across differences in which kidneys were accepted, an anti-MHC anti- 
body response developed, and rejection was recessive. In man, the DR 6 class II 
antigen has been found to be associated with significantly higher levels of renal 
allograft rejection than other DR types (24).  This  may be more analogous to 
class II immune response genes described in mice for soluble antigens. Another 
possible explanation for this difference in survival would be the existence of an 
unknown background gene(s). As the dd and gg herds have been separated for 
several generations, it is possible that a  background rejector gene(s) has been 
fixed  in  the  dd  herd.  This  would  have  to  be  different from  the  previously 
demonstrated  gene(s),  which  results  in  rejection  across  minor  antigen-only 
differences, since the dd animals used in these transplants did not have this gene 
(14). Therefore, there would be at least two non-MHC-linked immune response 
genes, one of which is only apparent when a strong, class  I  MHC difference is 
provided. A final explanation for the difference is suggested by a recent report 
by Isakov (25), who found a direct correlation between cytotoxic cell precursor 
frequency and the ability to reject thyroid allografts in murine D region disparate 
grafts. Because the gg and dd recipients differ at the class I antigen, they also see 
different class  I  antigens as foreign.  In  swine,  then,  CTL  precursors reactive 
against the class I antigens of d (AB  d) (gg anti-dg) would be of lower frequency 
than CTL precursors reactive against the class I antigen of g (AB  c) (dd anti-dg). 
The fact that heterozygous ad animals sometimes accept kidneys could then be 
explained  by  genetic  tolerance  to  a  greater  number  of class  I  specificities. 
Although formal precursor frequency analysis has not been done in these pigs, 
in vitro CTL activity is generally greater in AB  d anti-AB  c combinations than in 
ABc anti-AB  d combinations (19). 
Third, as mentioned in the introduction, a non-MHC-linked immune response 
gene has been shown to regulate survival across minor histocompatibility antigens 
in swine (14). The bimodal distribution of survival seen in some class II-matched 
groups  was  similar  to  that  seen  for  transplants  across  these  minor ~  antigen 
differences. Since the rejector phenotype for minor antigens segregated in the c 
herd (and probably the a  herd) to which the original g  haplotype animal was 
mated, it would be expected that a fraction of g haplotype animals should reject 
MHC-matched grafts and,  even  more likely, should  reject MHC-mismatched 
grafts.  If this bimodal distribution truly resulted from an inheritable recipient 
genotype, then the progeny of tolerant parents should all be acceptors. Breedings 
are currently underway to test this hypothesis. Since the dd recipients were all 
of the acceptor phenotype (14), this gene should not have been relevant in this 
limited group. 
The tolerance developed to the kidney appears to be systemic. First, there was 
prolongation of donor-specific skin  but  not of third-party skin.  The rejection 
that finally did ensue was possibly related to skin-specific antigens, since there 
was no associated evidence of renal dysfunction. In addition, no antibody was 
detectable nor did in  vitro cellular activity develop after skin  graft rejection. 
Experiments are currently underway to determine whether continued presence 
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The mechanism of tolerance maintenance is likewise presently under study. 
Suppressor cells active in an in vitro MLR response have been identified in the 
long-term survivors (reference 26 and unpublished data) and the phenotype of 
the cells involved is now being addressed, using monoclonal antibodies to porcine 
helper and CTL subsets (27). Whether these cells function in vivo in addition to 
in vitro is uncertain. The failure to detect a switch in the anti-MHC IgM response 
to IgG in the long-term survivors could indicate another phase in the immune 
response in which to study suppression in vitro. The ultimate test of suppressor 
cell regulation--passive cellular transfer--may not be possible in  these swine, 
since they are not fully syngeneic. 
These  experiments  may be  of clinical  relevance.  The  results  suggest  that 
matching for class II MHC antigens has a major role in vascular graft acceptance. 
They also suggest that other risk factors could be identified that lead to rejection. 
If  these  factors  could  be  identified  pretransplant,  better-matched  grafts  or 
adjustment of immunosuppressive regimens could be adopted. 
Summary 
The  benefit  of class  II  major  histocompatibility  complex  (MHC)  antigen 
matching to renal aliograft survival, in the absence of immunosuppression, has 
been  studied  in  partially  inbred  miniature  swine.  Permanent  (>6  mo)  renal 
allograft survival was found in  30% of recipents of either class  II only or fully 
matched grafts. Analysis of the survival of the class  II-only matched grafts by 
specific recipient/donor haplotype combinations indicated that survival was reg- 
ulated by at least three genetic factors, including antigen gene dose, a  class  I 
MHC allele-dependent effect, and non-MHC-linked immune response phenom- 
enon. 
Animals accepting class II-matched kidneys developed spontaneous tolerance 
to  the  graft,  despite  mounting an  initial  immune response  marked by  renal 
damage and the development of serum cytotoxic antibodies directed at the donor 
MHC  antigens.  The  antibodies  were  only of the  IgM  class,  suggesting  that 
conversion of the humoral response to IgG was blocked. After acceptance of the 
kidney, three out of five animals showed specific prolongation  of donor skin 
grafts. At the time of rejection of these skin grafts, no decrease in renal function 
nor reappearance of anti-donor antibodies was observed. 
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